<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122665">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01863472</url>
  </required_header>
  <id_info>
    <org_study_id>FF20/13 Version 03</org_study_id>
    <nct_id>NCT01863472</nct_id>
  </id_info>
  <brief_title>Catheter Ablation of Drug-refractory Persistent Atrial Fibrillation With the HeartLight(TM) Laser Balloon in Comparison With Irrigated Radiofrequency Current Ablation</brief_title>
  <official_title>Catheter Ablation of Drug-refractory Persistent Atrial Fibrillation With the HeartLight(TM) Laser Balloon in Comparison With Irrigated Radiofrequency Current Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boris Schmidt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardioangiologisches Centrum Bethanien</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to compare the safety and efficacy of pulmonary vein isolation using the
      endoscopic ablation system in comparison to irrigated radiofrequency current ablation in
      patients with drug-refractory persistent atrial fibrillation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Documented recurrence of atrial fibrillation or any atrial tachyarrhythmia &gt;30 seconds</measure>
    <time_frame>between day 90 and 365 days after index procedure</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Persistent Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>HeartLight(TM) Laser Balloon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Safety and efficacy of pulmonary vein isolation using the HeartLight(TM) Laser Balloon (endoscopically guided ablation)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>irrigated radiofrequency current ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Safety and efficacy of pulmonary vein isolation using the irrigated radiofrequency current ablation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HeartLight(TM) Laser Balloon</intervention_name>
    <description>With the HeartLight(TM) Laser Balloon pulmonary vein isolation is done endoscopically guided</description>
    <arm_group_label>HeartLight(TM) Laser Balloon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>irrigated radiofrequency current ablation</intervention_name>
    <description>The irrigated radiofrequency current ablation is used for pulmonary vein isolation</description>
    <arm_group_label>irrigated radiofrequency current ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 80 years

          -  persistent atrial fibrillation

          -  failure of at least one antiarrhythmic drug

          -  others

        Exclusion Criteria:

          -  contraindications for pulmonary vein isolation (PVI)

          -  previous PVI attempts

          -  inability to be treated with oral anticoagulation

          -  presence of intracardiac thrombi

          -  pregnancy

          -  others
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boris Schmidt, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardioangiologisches Centrum Bethanien</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Boris Schmidt, Dr</last_name>
    <phone>+49 69945028</phone>
    <phone_ext>110</phone_ext>
    <email>b.schmidt@ccb.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Herz- und Gefäß-Klinik GmbH Bad Neustadt</name>
      <address>
        <city>Bad Neustadt</city>
        <state>Bavaria</state>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Deneke, PD Dr.</last_name>
      <phone>+49 9771662602</phone>
      <email>Thomas.Deneke@kardiologie-bad-neustadt.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Deneke, PB Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rheinische Friedrich-Wilhelms-Universität Bonn</name>
      <address>
        <city>Bonn</city>
        <state>NRW</state>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Schrickel, Prof. Dr.</last_name>
      <phone>+49 22828714983</phone>
      <email>jan.schrickel@ukb.uni-bonn.de</email>
    </contact>
    <investigator>
      <last_name>Jan Schrickel, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardioangiologisches Centrum Bethanien</name>
      <address>
        <city>Frankfurt/Main</city>
        <zip>60431</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris Schmidt, Dr.</last_name>
      <phone>+4969945028</phone>
      <phone_ext>110</phone_ext>
      <email>b.schmidt@ccb.de</email>
    </contact>
    <investigator>
      <last_name>Boris Schmidt, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Karlsruhe, Medizinische Klinik IV</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Armin Luik, Dr.</last_name>
      <phone>+49 721 974 0</phone>
      <email>armin.luik@klinikum-karlsruhe.de</email>
    </contact>
    <investigator>
      <last_name>Armin Luik, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 2, 2014</lastchanged_date>
  <firstreceived_date>May 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cardioangiologisches Centrum Bethanien</investigator_affiliation>
    <investigator_full_name>Boris Schmidt</investigator_full_name>
    <investigator_title>Arzt für Kardiologie</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
